OBJECTIVE: To determine differences in patient characteristics, antiretroviral therapy (ART) regimen characteristics, and regimen refill adherence for human immunodeficiency virus (HIV)-focused pharmacy (HIV-P) versus traditional pharmacy (TP) users. DESIGN: Retrospective cohort study. SETTING: California Walgreens pharmacies from May 2007 to August 2009. PARTICIPANTS: HIV-positive patients with greater than 30 days of antiretroviral prescription claims. INTERVENTION: Deidentified prescription records for patients filling any ART prescription at any California Walgreens pharmacy during the study period were assessed. MAIN OUTCOME MEASURES: ART regimen refill adherence (calculated by modified medication possession ratio [mMPR]) and dichotomous measure of optimal adherence of 95% or greater. RESULTS: 4,254 HIV-P and 11,679 TP users were included. Compared with TP users, HIV-P users traveled farther to pharmacies (5.03 vs. 1.26 miles, P < 0.01). A greater proportion of HIV-P users filled prescriptions for chronic diseases (35% vs. 30%) and received fixed-dose combination antiretroviral tablets (92% vs. 83%) (all P < 0.01). Median mMPR was higher for HIV-P users (90% vs. 77%, P < 0.0001). After adjusting for age, gender, insurance, medication use, and distance from pharmacy, use of HIV-P (odds ratio 1.90 [95% CI 1.72-2.08]) and fixed-dose combination antiretroviral tablets (3.34 [2.84-3.96]) were most strongly associated with having 95% or greater ART regimen refill adherence. CONCLUSION: For HIV-positive patients struggling with antiretroviral adherence, clinicians may consider minimizing pill burden with combination tablets and referral to an HIV-focused pharmacy.
OBJECTIVE: To determine differences in patient characteristics, antiretroviral therapy (ART) regimen characteristics, and regimen refill adherence for human immunodeficiency virus (HIV)-focused pharmacy (HIV-P) versus traditional pharmacy (TP) users. DESIGN: Retrospective cohort study. SETTING: California Walgreens pharmacies from May 2007 to August 2009. PARTICIPANTS: HIV-positivepatients with greater than 30 days of antiretroviral prescription claims. INTERVENTION: Deidentified prescription records for patients filling any ART prescription at any California Walgreens pharmacy during the study period were assessed. MAIN OUTCOME MEASURES: ART regimen refill adherence (calculated by modified medication possession ratio [mMPR]) and dichotomous measure of optimal adherence of 95% or greater. RESULTS: 4,254 HIV-P and 11,679 TP users were included. Compared with TP users, HIV-P users traveled farther to pharmacies (5.03 vs. 1.26 miles, P < 0.01). A greater proportion of HIV-P users filled prescriptions for chronic diseases (35% vs. 30%) and received fixed-dose combination antiretroviral tablets (92% vs. 83%) (all P < 0.01). Median mMPR was higher for HIV-P users (90% vs. 77%, P < 0.0001). After adjusting for age, gender, insurance, medication use, and distance from pharmacy, use of HIV-P (odds ratio 1.90 [95% CI 1.72-2.08]) and fixed-dose combination antiretroviral tablets (3.34 [2.84-3.96]) were most strongly associated with having 95% or greater ART regimen refill adherence. CONCLUSION: For HIV-positivepatients struggling with antiretroviral adherence, clinicians may consider minimizing pill burden with combination tablets and referral to an HIV-focused pharmacy.
Authors: Christie A Robinson; Jennifer Cocohoba; Conan MacDougall; Malcolm D V John; B Joseph Guglielmo Journal: J Am Pharm Assoc (2003) Date: 2007 Sep-Oct
Authors: D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh Journal: Ann Intern Med Date: 2000-07-04 Impact factor: 25.391
Authors: Robert Gross; Benita Yip; Vincent Lo Re; Evan Wood; Christopher S Alexander; P Richard Harrigan; David R Bangsberg; Julio S G Montaner; Robert S Hogg Journal: J Infect Dis Date: 2006-09-12 Impact factor: 5.226
Authors: David R Bangsberg; Edward P Acosta; Reena Gupta; David Guzman; Elise D Riley; P Richard Harrigan; Neil Parkin; Steven G Deeks Journal: AIDS Date: 2006-01-09 Impact factor: 4.177
Authors: Shuntai Zhou; Kelly Martin; Amanda Corbett; Sonia Napravnik; Joseph Eron; Ye Zhu; Bryan Casciere; Cindy Boulton; Brittany Loy; Shayna Smith; Amanda Woods; Margaret Murray; Laura Ramsdell; David A Wohl Journal: AIDS Patient Care STDS Date: 2014-06 Impact factor: 5.078
Authors: Kathy K Byrd; Felicia Hardnett; Patrick G Clay; Ambrose Delpino; Ron Hazen; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Paul J Weidle Journal: AIDS Patient Care STDS Date: 2019-01-16 Impact factor: 5.078
Authors: Patricia Murphy; Jennifer Cocohoba; Andrew Tang; Glen Pietrandoni; John Hou; B Joseph Guglielmo Journal: AIDS Patient Care STDS Date: 2012-08-03 Impact factor: 5.078
Authors: Ram K Shrestha; Jon C Schommer; Michael S Taitel; Oscar W Garza; Nasima M Camp; Osayi E Akinbosoye; Patrick G Clay; Kathy K Byrd Journal: J Acquir Immune Defic Syndr Date: 2020-11-01 Impact factor: 3.771